Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

FDG-PET and MRI in the Evolution of New-Onset Refractory Status Epilepticus.

Strohm T, Steriade C, Wu G, Hantus S, Rae-Grant A, Larvie M.

AJNR Am J Neuroradiol. 2019 Feb;40(2):238-244. doi: 10.3174/ajnr.A5929. Epub 2019 Jan 24.

2.

Localization yield and seizure outcome in patients undergoing bilateral SEEG exploration.

Steriade C, Martins W, Bulacio J, Morita-Sherman ME, Nair D, Gupta A, Bingaman W, Gonzalez-Martinez J, Najm I, Jehi L.

Epilepsia. 2019 Jan;60(1):107-120. doi: 10.1111/epi.14624. Epub 2018 Dec 26.

3.

Electroclinical features of seizures associated with autoimmune encephalitis.

Steriade C, Moosa ANV, Hantus S, Prayson RA, Alexopoulos A, Rae-Grant A.

Seizure. 2018 Aug;60:198-204. doi: 10.1016/j.seizure.2018.06.021. Epub 2018 Jun 28.

4.

Long-Term Cognitive Outcomes in Patients with Autoimmune Encephalitis.

H├ębert J, Day GS, Steriade C, Wennberg RA, Tang-Wai DF.

Can J Neurol Sci. 2018 Sep;45(5):540-544. doi: 10.1017/cjn.2018.33. Epub 2018 Jun 25.

PMID:
29936915
5.

Claustrum hyperintensities: A potential clue to autoimmune epilepsy.

Steriade C, Tang-Wai DF, Krings T, Wennberg R.

Epilepsia Open. 2017 Sep 12;2(4):476-480. doi: 10.1002/epi4.12077. eCollection 2017 Dec.

6.

Extreme delta - With or without brushes: A potential surrogate marker of disease activity in anti-NMDA-receptor encephalitis.

Steriade C, Hantus S, Moosa ANV, Rae-Grant AD.

Clin Neurophysiol. 2018 Oct;129(10):2197-2204. doi: 10.1016/j.clinph.2018.02.130. Epub 2018 Mar 10.

PMID:
29580710
7.

Frontal infraslow activity marks the motor spasms of anti-LGI1 encephalitis.

Wennberg R, Steriade C, Chen R, Andrade D.

Clin Neurophysiol. 2018 Jan;129(1):59-68. doi: 10.1016/j.clinph.2017.10.014. Epub 2017 Oct 28.

8.

Subclinical temporal EEG seizure pattern in LGI1-antibody-mediated encephalitis.

Steriade C, Mirsattari SM, Murray BJ, Wennberg R.

Epilepsia. 2016 Aug;57(8):e155-60. doi: 10.1111/epi.13436. Epub 2016 Jun 13.

9.

Clinical Reasoning: A 64-year-old man with progressive paraspinal muscle weakness.

Schneider R, Steriade C, Ashby P, Kiehl TR.

Neurology. 2016 Jan 5;86(1):e4-9. doi: 10.1212/WNL.0000000000002241. No abstract available.

PMID:
26712835
10.

Clinical Reasoning: A 66-year-old man with recurrent multi-territory infarcts.

Kouzmitcheva E, Steriade C, Prica A, Hazrati LN, Mandell DM.

Neurology. 2015 Jun 9;84(23):e195-201. doi: 10.1212/WNL.0000000000001662. No abstract available.

PMID:
26054898
11.

Reply from the authors.

Steriade C, Andrade DM, Faghfoury H, Tarnopolsky MA, Tai P.

Pediatr Neurol. 2014 Aug;51(2):e5-6. doi: 10.1016/j.pediatrneurol.2014.05.024. Epub 2014 May 29. No abstract available.

PMID:
25079585
12.

A 54-year-old man with hallucinations and hearing loss.

Steriade C, Shumak SL, Feinstein A.

CMAJ. 2014 Nov 18;186(17):1315-8. doi: 10.1503/cmaj.131535. Epub 2014 Jun 30. No abstract available. Erratum in: CMAJ. 2015 Apr 7;187(6):439.

13.

Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet.

Steriade C, Andrade DM, Faghfoury H, Tarnopolsky MA, Tai P.

Pediatr Neurol. 2014 May;50(5):498-502. doi: 10.1016/j.pediatrneurol.2014.01.009. Epub 2014 Jan 7.

PMID:
24656211
14.

LGI1 autoantibodies associated with cerebellar degeneration.

Steriade C, Day GS, Lee L, Murray BJ, Fritzler MJ, Keith J.

Neuropathol Appl Neurobiol. 2014 Aug;40(5):645-9. doi: 10.1111/nan.12132. No abstract available.

PMID:
24606111
15.

The transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.

Luk KC, Rymar VV, van den Munckhof P, Nicolau S, Steriade C, Bifsha P, Drouin J, Sadikot AF.

J Neurochem. 2013 Jun;125(6):932-43. doi: 10.1111/jnc.12160. Epub 2013 Mar 6.

Supplemental Content

Loading ...
Support Center